Literature DB >> 16052629

Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins.

Robert L Moritz1, Andrew B Clippingdale, Eugene A Kapp, James S Eddes, Hong Ji, Sam Gilbert, Lisa M Connolly, Richard J Simpson.   

Abstract

Free-flow electrophoresis (FFE) and rapid (6 min) RP-HPLC was used to fractionate human citrate-treated plasma. Prior to analysis, the six most abundant proteins in plasma were removed by immunoaffinity chromatography; both depleted plasma and the fraction containing the six abundant proteins depleted were taken for MS-based analysis. Fractionated proteins were digested with trypsin and the generated peptides were subjected to MS-based peptide sequencing. To date, 78 plasma proteins have been unambiguously identified by manual validation from 16% (15/96 FFE total fractions) of the collected FFE pools; 55 identifications were based on > or = 2 tryptic peptides and 23 using single peptides. The molecular weight range of proteins and peptides isolated by this method ranged from approximately 190 K (e.g., Complement C3 and C4) to approximately 4-6 K (e.g., CRISPP and Apolipoprotein C1). This FFE/RP-HPLC approach reveals low-abundance proteins and peptides (e.g., L-Selectin approximately 17 ng/mL and the cancer-associated SCM-recognition, immunodefense suppression, and serine protease protection peptide (CRISPP) at approximately 0.5-1 ng/mL), where CRISPP was found in association with alpha-1-antitrypsin as a non-covalent complex, in the fraction containing the depleted high-abundance proteins. In contrast to shotgun proteomic approaches, the FFE/RP-HPLC method described here allows the identification of potentially interesting peptides to be traced back to their protein of origin, and for the first time, has confirmed the "protein sponge" hypothesis where the 35 residue CRISPP polypeptide is non-covalently complexed with the major circulating plasma protein alpha-1-antitrypsin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052629     DOI: 10.1002/pmic.200500096

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

Review 1.  Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.

Authors:  Wei-Jun Qian; Jon M Jacobs; Tao Liu; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-08-03       Impact factor: 5.911

2.  Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution.

Authors:  Hasmik Keshishian; Terri Addona; Michael Burgess; Eric Kuhn; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2007-10-15       Impact factor: 5.911

Review 3.  Protein analysis by shotgun/bottom-up proteomics.

Authors:  Yaoyang Zhang; Bryan R Fonslow; Bing Shan; Moon-Chang Baek; John R Yates
Journal:  Chem Rev       Date:  2013-02-26       Impact factor: 60.622

Review 4.  Multi-dimensional liquid chromatography in proteomics--a review.

Authors:  Xiang Zhang; Aiqin Fang; Catherine P Riley; Mu Wang; Fred E Regnier; Charles Buck
Journal:  Anal Chim Acta       Date:  2010-02-06       Impact factor: 6.558

Review 5.  Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective.

Authors:  Henry Rodriguez; Robert Rivers; Christopher Kinsinger; Mehdi Mesri; Tara Hiltke; Amir Rahbar; Emily Boja
Journal:  Proteomics Clin Appl       Date:  2010-11-22       Impact factor: 3.494

6.  Application of free-flow electrophoresis/2-dimentional gel electrophoresis for fractionation and characterization of native proteome of Pseudomonas putida KT2440.

Authors:  Chi-Won Choi; Young S Hong; Seung Il Kim
Journal:  J Microbiol       Date:  2008-08-31       Impact factor: 3.422

7.  Functional and complementary phosphorylation state attributes of human insulin-like growth factor-binding protein-1 (IGFBP-1) isoforms resolved by free flow electrophoresis.

Authors:  Mikkel Nissum; Majida Abu Shehab; Ute Sukop; Javad M Khosravi; Robert Wildgruber; Christoph Eckerskorn; Victor K M Han; Madhulika B Gupta
Journal:  Mol Cell Proteomics       Date:  2009-02-03       Impact factor: 5.911

Review 8.  Recent developments in CE and CEC of peptides.

Authors:  Václav Kasicka
Journal:  Electrophoresis       Date:  2008-01       Impact factor: 3.535

9.  Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer.

Authors:  Tatsuhiko Kakisaka; Tadashi Kondo; Tetsuya Okano; Kiyonaga Fujii; Kazufumi Honda; Mitsufumi Endo; Akihiko Tsuchida; Tatsuya Aoki; Takao Itoi; Fuminori Moriyasu; Tesshi Yamada; Harubumi Kato; Toshihide Nishimura; Satoru Todo; Setsuo Hirohashi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-01       Impact factor: 3.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.